COM:PHARMAENGINE
智擎生技製藥股份有限公司
- Stock
Last Close
96.20
22/11 05:30
Market Cap
13.67B
Beta: -
Volume Today
845.11K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 5.09M - | 13.17M 158.61% | 17.85M 35.56% | 21.83M 22.30% | 24.43M 11.88% | 15.09M 38.24% | 19.90M 31.94% | 25.14M 26.30% | ||||
average payables | 10.04M - | 10.04M 0% | ||||||||||
average receivables | 8.08M - | 396.19M 4,806.04% | 456.85M 15.31% | 138.04M 69.78% | 444.75M 222.19% | 470.34M 5.75% | 94.90M 79.82% | 247.71M 161.04% | ||||
book value per share | 20.11 - | 20.21 0.52% | 21.56 6.68% | 25.93 20.24% | 26.59 2.54% | 25.11 5.56% | 23.91 4.79% | 27.54 15.21% | 27.25 1.07% | 26.59 2.42% | 26.87 1.07% | |
capex per share | -0.00 - | -0.08 12,176.93% | -0.01 90.29% | -0.00 57.50% | -0.00 4.28% | -0.00 58.81% | -0.00 192.43% | -0.00 62.05% | -0.03 1,609.43% | -0.01 75.39% | ||
capex to depreciation | -0.34 - | -7.22 2,028.82% | -0.38 94.70% | -0.16 58.03% | -0.17 8.46% | -0.03 82.20% | -0.05 56.12% | -0.02 53.91% | -0.46 1,952.68% | -0.11 76.82% | ||
capex to operating cash flow | -0.00 - | -0.03 3,535.11% | -0.00 95.00% | 0.00 209.46% | -0.00 147.49% | -0.01 1,790.38% | -0.01 27.44% | -0.00 97.38% | -0.02 7,825.94% | -0.00 80.90% | ||
capex to revenue | -0.00 - | -0.02 5,508.21% | -0.00 95.66% | -0.00 43.28% | -0.00 203.42% | -0.00 61.89% | -0.00 13.07% | -0.00 39.26% | -0.01 1,623.46% | -0.00 79.29% | ||
cash per share | 19.98 - | 20.02 0.18% | 21.52 7.48% | 26.68 23.99% | 22.28 16.47% | 24.90 11.73% | 23.44 5.83% | 23.30 0.60% | 26.39 13.22% | 25.14 4.71% | 25.24 0.39% | |
days of inventory on hand | 1.86K - | 2.08K 12.06% | 553.95 73.37% | 276.81 50.03% | 242.51 12.39% | 53.48 77.95% | 252.46 372.06% | 119.18 52.79% | ||||
days payables outstanding | 568.93 - | |||||||||||
days sales outstanding | 5.19 - | 331.88 6,288.60% | 171.01 48.47% | 161.10 5.79% | 259.54 61.10% | 105.79 59.24% | 129.13 - | |||||
debt to assets | 0.00 - | 0.00 36.37% | 0.00 84.48% | 0.00 93.75% | 0.00 103.57% | 0.00 94.63% | 0.01 2,960.98% | 0.01 42.70% | 0.00 64.07% | 0.01 198.73% | 0.00 33.52% | |
debt to equity | 0.00 - | 0.00 36.58% | 0.00 87.96% | 0.00 93.65% | 0.00 105.30% | 0.00 92.81% | 0.01 2,974.86% | 0.01 42.55% | 0.00 64.98% | 0.01 199.36% | 0.00 33.57% | |
dividend yield | 0.00 - | 0.00 10.00% | 0.01 140.05% | 0.02 66.07% | 0.01 20.10% | 0.01 40.82% | 0.03 301.57% | 0.02 38.60% | 0.02 14.72% | |||
earnings yield | -0.01 - | 0.00 171.70% | 0.02 279.24% | 0.03 93.26% | 0.02 44.19% | 0.01 53.76% | 0.00 46.90% | 0.07 1,580.88% | 0.04 43.35% | 0.02 56.87% | 0.02 0.81% | |
enterprise value | 17.20B - | 26.21B 52.37% | 24.04B 8.28% | 20.32B 15.48% | 21.71B 6.84% | 15.75B 27.45% | 9.92B 37.03% | 6.62B 33.29% | 8.35B 26.18% | 16.46B 97.07% | 14.95B 9.15% | |
enterprise value over ebitda | -123.64 - | 370.10 399.34% | 73.09 80.25% | 25.05 65.72% | 35.25 40.68% | 347.22 885.13% | 175.62 49.42% | 8.65 95.08% | 15.03 73.82% | 41.02 172.97% | 52.24 27.34% | |
ev to operating cash flow | -363.20 - | 199.97 155.06% | 53.67 73.16% | 23.35 56.50% | -63.99 374.07% | 21.14 133.03% | 616.99 2,818.89% | 102.18 83.44% | 8.98 91.21% | 81.46 806.94% | 58.18 28.58% | |
ev to sales | 459.99 - | 114.48 75.11% | 47.40 58.60% | 17.91 62.22% | 25.43 42.02% | 53.68 111.08% | 31.59 41.16% | 6.27 80.16% | 12.75 103.48% | 25.15 97.21% | 19.48 22.56% | |
free cash flow per share | -0.35 - | 0.90 358.18% | 2.98 229.07% | 5.93 99.27% | -2.31 138.93% | 5.06 319.15% | 0.11 97.85% | 0.44 304.46% | 6.43 1,359.49% | 1.36 78.85% | 1.78 30.95% | |
free cash flow yield | -0.00 - | 0.00 289.07% | 0.02 296.12% | 0.04 120.04% | -0.02 138.87% | 0.05 403.20% | 0.00 96.56% | 0.01 378.51% | 0.09 1,063.97% | 0.01 87.72% | 0.02 48.80% | |
graham net net | 19.79 - | 19.89 0.52% | 20.97 5.43% | 25.70 22.53% | 24.94 2.97% | 24.63 1.24% | 23.14 6.03% | 25.91 11.98% | 26.78 3.36% | 24.61 8.10% | 26.08 5.96% | |
graham number | 19.86 - | 19.70 0.80% | 36.12 83.33% | 52.40 45.06% | 39.67 24.29% | 22.29 43.82% | 12.53 43.76% | 50.71 304.59% | 42.51 16.17% | 36.19 14.87% | 33.99 6.08% | |
income quality | 0.40 - | 1.05 162.34% | 1.10 4.39% | 1.04 5.63% | -0.68 165.72% | 4.55 766.51% | 0.32 92.89% | 0.09 73.41% | 1.70 1,880.35% | 0.51 69.80% | 0.94 81.77% | |
intangibles to total assets | 0.00 - | 0.00 50.08% | 0.00 639.49% | 0.00 9.12% | 0.00 0.31% | 0.00 5.11% | 0.00 25.29% | 0.00 68.33% | 0.00 24.67% | 0.00 326.77% | 0.00 24.70% | |
interest coverage | 444.46 - | 1.70K 282.40% | 2.57K 51.37% | 5.10K 98.17% | 894.14 82.46% | |||||||
interest debt per share | 0.02 - | 0.01 36.25% | 0.03 100.51% | 0.00 92.36% | 0.00 110.52% | 0.01 82.10% | 0.23 2,837.53% | 0.15 32.70% | 0.05 65.08% | 0.15 185.15% | 0.11 31.69% | |
inventory turnover | 0.20 - | 0.18 10.76% | 0.66 275.45% | 1.32 100.12% | 1.51 14.14% | 6.82 353.46% | 1.45 78.82% | 3.06 111.82% | ||||
invested capital | 0.00 - | 0.00 36.58% | 0.00 87.96% | 0.00 93.65% | 0.00 105.30% | 0.00 92.81% | 0.01 2,974.86% | 0.01 42.55% | 0.00 64.98% | 0.01 199.36% | 0.00 33.57% | |
market cap | 19.90B - | 29.11B 46.27% | 24.47B 15.94% | 22.16B 9.44% | 22.29B 0.56% | 16.11B 27.72% | 9.98B 38.05% | 8.43B 15.51% | 10.49B 24.45% | 18.20B 73.47% | 15.81B 13.14% | |
net current asset value | 2.69B - | 2.90B 7.59% | 3.08B 6.46% | 3.78B 22.41% | 3.87B 2.54% | 3.67B 5.27% | 3.42B 6.80% | 3.97B 16.27% | 3.92B 1.33% | 3.83B 2.29% | 3.83B 0.01% | |
net debt to ebitda | 19.39 - | -40.89 310.89% | -1.30 96.81% | -2.27 74.19% | -0.93 58.89% | -7.87 743.89% | -1.05 86.64% | -2.37 125.30% | -3.86 62.78% | -4.35 12.88% | -3.01 30.92% | |
net income per share | -0.87 - | 0.85 197.91% | 2.69 215.06% | 4.71 75.01% | 2.63 44.10% | 0.88 66.58% | 0.29 66.78% | 4.15 1,320.77% | 2.95 28.97% | 2.19 25.73% | 1.91 12.72% | |
operating cash flow per share | -0.35 - | 0.91 358.36% | 3.06 237.73% | 5.94 94.27% | -2.31 138.83% | 5.07 319.61% | 0.11 97.82% | 0.44 303.01% | 6.43 1,346.15% | 1.39 78.43% | 1.79 28.87% | |
payables turnover | 0.64 - | |||||||||||
receivables turnover | 70.26 - | 1.10 98.43% | 2.13 94.08% | 2.27 6.15% | 1.41 37.93% | 3.45 145.34% | 2.83 - | |||||
research and ddevelopement to revenue | 2.51 - | 0.50 80.02% | 0.23 54.92% | 0.17 24.13% | 0.14 16.80% | 0.43 198.03% | 0.42 2.13% | 0.09 78.23% | 0.21 130.60% | 0.28 32.96% | 0.40 45.42% | |
return on tangible assets | -0.04 - | 0.04 197.73% | 0.12 189.90% | 0.17 43.17% | 0.09 45.94% | 0.03 64.28% | 0.01 65.27% | 0.14 1,130.03% | 0.11 26.34% | 0.08 24.01% | 0.07 13.58% | |
revenue per share | 0.28 - | 1.58 471.59% | 3.46 118.91% | 7.75 123.70% | 5.80 25.07% | 1.99 65.63% | 2.16 8.08% | 7.25 236.41% | 4.53 37.52% | 4.49 0.81% | 5.34 18.85% | |
roe | -0.04 - | 0.04 197.40% | 0.12 195.33% | 0.18 45.55% | 0.10 45.48% | 0.04 64.62% | 0.01 65.11% | 0.15 1,133.18% | 0.11 28.20% | 0.08 23.89% | 0.07 13.64% | |
roic | -0.05 - | 0.02 146.72% | 0.10 318.32% | 0.18 74.75% | 0.12 30.29% | 0.01 92.57% | 0.01 32.45% | 0.15 1,140.88% | 0.11 27.73% | 0.08 24.45% | 0.06 28.78% | |
sales general and administrative to revenue | 1.68 - | 0.16 90.49% | 0.12 27.90% | 0.09 21.47% | 0.09 1.77% | 0.26 197.30% | 0.27 1.07% | 0.07 72.93% | 0.12 72.77% | 0.15 16.34% | 0.12 16.54% | |
shareholders equity per share | 20.11 - | 20.21 0.52% | 21.56 6.68% | 25.93 20.24% | 26.59 2.54% | 25.11 5.56% | 23.91 4.79% | 27.54 15.21% | 27.25 1.07% | 26.59 2.42% | 26.87 1.07% | |
stock based compensation to revenue | 1.69 - | 0.06 96.35% | 0.04 36.27% | 0.05 38.15% | 0.02 62.60% | 0.05 156.24% | 0.02 64.21% | -0.00 105.37% | 0.00 113.60% | 0.00 2,561.39% | 0.00 21.72% | |
tangible asset value | 2.72B - | 2.93B 7.67% | 3.16B 7.93% | 3.80B 20.24% | 3.91B 2.95% | 3.69B 5.55% | 3.48B 5.71% | 4.01B 15.15% | 3.94B 1.80% | 3.87B 1.74% | 3.86B 0.22% | |
tangible book value per share | 20.11 - | 20.21 0.52% | 21.56 6.68% | 25.93 20.24% | 26.59 2.54% | 25.11 5.56% | 23.91 4.79% | 27.54 15.21% | 27.25 1.07% | 26.59 2.42% | 26.87 1.07% | |
working capital | 2.69B - | 2.90B 7.58% | 3.10B 6.91% | 3.79B 22.23% | 3.87B 2.26% | 3.67B 5.27% | 3.44B 6.20% | 3.99B 15.86% | 3.92B 1.61% | 3.85B 1.89% | 3.84B 0.21% |
All numbers in (except ratios and percentages)